In particular, interleukin-1β (IL-1β) has been involved in the pathogenesis of type 1 and type 2 diabetes [15,16], as well as in the development of the diabetic retinopathy associated to type 1 diabetes [17,18]. Here, IL1B is linked to type 2 diabetes mellitus.